propranolol has been researched along with Fibrosarcoma in 2 studies
Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
Fibrosarcoma: A sarcoma derived from deep fibrous tissue, characterized by bundles of immature proliferating fibroblasts with variable collagen formation, which tends to invade locally and metastasize by the bloodstream. (Stedman, 25th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate the effect of propranolol on efficacy of HSP-70 rich lysate vaccine in immunotherapy of fibrosarcoma." | 7.79 | Long acting propranolol and HSP-70 rich tumor lysate reduce tumor growth and enhance immune response against fibrosarcoma in Balb/c mice. ( Hassan, ZM; Haybar, H; Khalili, A; Langroudi, L; Mahdavi, M; Noori, S; Ostad, SN; Pourfathollah, AA; Shahabi, S, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Khalili, A | 1 |
| Hassan, ZM | 1 |
| Shahabi, S | 1 |
| Pourfathollah, AA | 1 |
| Ostad, SN | 1 |
| Noori, S | 1 |
| Mahdavi, M | 1 |
| Haybar, H | 1 |
| Langroudi, L | 1 |
| Bloksma, N | 1 |
| Hofhuis, FM | 1 |
| Willers, JM | 1 |
2 other studies available for propranolol and Fibrosarcoma
| Article | Year |
|---|---|
Long acting propranolol and HSP-70 rich tumor lysate reduce tumor growth and enhance immune response against fibrosarcoma in Balb/c mice.
Topics: Adrenergic beta-Antagonists; Animals; Cancer Vaccines; Cell Extracts; Cell Line, Tumor; Cell Prolife | 2013 |
Effect of adrenoceptor blockade on hemorrhagic necrosis of meth A sarcomata induced by endotoxin or tumor necrosis serum.
Topics: Animals; Dose-Response Relationship, Drug; Endotoxins; Female; Fibrosarcoma; Immune Sera; Mice; Necr | 1982 |